Citadel Advisors
LFST icon

Citadel Advisors’s Lifestance Health LFST Stock Holding History

Citadel Advisors’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Sell
514,292
-3,335,734
-87% -$25.8M ﹤0.01% 4556
2026
Q1 		$24.5M Buy
3,850,026
+3,810,205
+9,568% +$26.5M ﹤0.01% 2087
2025
Q4 		$280K Sell
39,821
-55,029
-58% -$332K ﹤0.01% 10283
2025
Q3 		$522K Sell
94,850
-1,320,451
-93% -$6.47M ﹤0.01% 9024
2025
Q2 		$7.32M Buy
1,415,301
+454,716
+47% +$2.72M ﹤0.01% 3486
2025
Q1 		$6.4M Buy
960,585
+501,806
+109% +$3.81M ﹤0.01% 3502
2024
Q4 		$3.38M Sell
458,779
-495,217
-52% -$3.55M ﹤0.01% 4633
2024
Q3 		$6.68M Sell
953,996
-389,163
-29% -$2.34M ﹤0.01% 3488
2024
Q2 		$6.59M Buy
1,343,159
+671,477
+100% +$4.05M ﹤0.01% 3336
2024
Q1 		$4.14M Buy
671,682
+398,426
+146% +$2.68M ﹤0.01% 4239
2023
Q4 		$2.14M Buy
273,256
+34,950
+15% +$225K ﹤0.01% 5235
2023
Q3 		$1.64M Buy
238,306
+46,741
+24% +$379K ﹤0.01% 5575
2023
Q2 		$1.75M Buy
191,565
+148,454
+344% +$1.23M ﹤0.01% 5392
2023
Q1 		$320K Buy
43,111
+42,761
+12,217% +$237K ﹤0.01% 9249
2022
Q4 		$1.73K Sell
350
-125,450
-100% -$776K ﹤0.01% 14425
2022
Q3 		$833K Buy
125,800
+36,323
+41% +$253K ﹤0.01% 7389
2022
Q2 		$497K Sell
89,477
-122,202
-58% -$936K ﹤0.01% 8672
2022
Q1 		$2.14M Sell
211,679
-24,776
-10% -$217K ﹤0.01% 5945
2021
Q4 		$2.25M Buy
+236,455
New +$2.51M ﹤0.01% 5968
2021
Q3 		– Sell
-554,866
Closed -$10.7M – 14284
2021
Q2 		$15.5M Buy
+554,866
New +$14.7M ﹤0.01% 2414

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors's LFST Position: Q2 2026 in Review

Citadel Advisors reduced its Lifestance Health (LFST) stake by 87% in Q2 2026, selling an estimated $25.8M and leaving 514,292 shares worth $5.51M. The position accounts for ﹤0.01% of the portfolio, ranked #4556.

Citadel Advisors first reported a position in LFST in Q2 2021 and has held it in 20 quarters since. The position peaked at $24.5M in Q1 2026. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Citadel Advisors held 514,292 shares of Lifestance Health worth $5.51M as of Q2 2026.
  • Citadel Advisors sold 3,335,734 Lifestance Health shares in Q2 2026, an estimated $25.8M.
  • Lifestance Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4556 holding.
  • Citadel Advisors first reported a position in Lifestance Health in Q2 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Lifestance Health position peaked at $24.5M in Q1 2026.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.